3,180 Shares in Axon Enterprise, Inc $AXON Bought by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd purchased a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 3,180 shares of the biotechnology company’s stock, valued at approximately $1,351,000.

A number of other institutional investors and hedge funds have also bought and sold shares of AXON. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the fourth quarter valued at about $28,000. Sound Income Strategies LLC grew its position in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Camelot Portfolios LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $30,000. AlphaCentric Advisors LLC bought a new stake in Axon Enterprise during the 4th quarter valued at approximately $34,000. Finally, Lodestone Wealth Management LLC bought a new stake in Axon Enterprise during the 4th quarter valued at approximately $35,000. 79.08% of the stock is owned by institutional investors.

Insider Activity

In related news, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. This trade represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the completion of the sale, the president owned 169,125 shares in the company, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 58,989 shares of company stock worth $30,527,983. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Axon Enterprise stock traded down $16.20 during midday trading on Friday, reaching $565.80. 762,731 shares of the stock traded hands, compared to its average volume of 1,119,821. The stock’s fifty day moving average is $457.90 and its 200-day moving average is $483.77. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The stock has a market cap of $45.60 billion, a P/E ratio of 227.23, a PEG ratio of 11.87 and a beta of 1.38. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same quarter last year, the business posted $1.47 EPS. The firm’s revenue for the quarter was up 33.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently commented on AXON. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a report on Thursday, May 7th. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research report on Monday, July 6th. Weiss Ratings raised shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Citizens Jmp restated a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. Finally, JPMorgan Chase & Co. raised their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $722.12.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.